Skip to Main content Skip to Navigation
Journal articles

Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis

Navina Chrobok 1 John Bol 1 Cornelis Jongenelen 1 John Brevé 1 Said El Alaoui 2 Javier Fidalgo-Lopez 3 Guy Fournet 3 Benoît Joseph 3 Micha Wilhelmus 1 Benjamin Drukarch 1 Anne-Marie van Dam 1 
1 Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
2 Covalab - Département Recherches [Villeurbanne, Lyon]
3 SMITh - Synthèse de Molécules d'Intérêt Thérapeutique
ICBMS - Institut de Chimie et Biochimie Moléculaires et Supramoléculaires
Document type :
Journal articles
Complete list of metadata
https://hal-udl.archives-ouvertes.fr/hal-02134577
Contributor : UMR5246 ICBMS Connect in order to contact the contributor
Submitted on : Monday, May 20, 2019 - 4:08:30 PM
Last modification on : Saturday, June 25, 2022 - 10:09:32 AM

Links full text

pubmedcentral

Identifiers

Collections

CNRS | UNIV-LYON1 | INSA-LYON | INC-CNRS | ICBMS | INSA-GROUPE | UDL

Citation

Navina Chrobok, John Bol, Cornelis Jongenelen, John Brevé, Said El Alaoui, et al.. Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS ONE, Public Library of Science, 2018, 13 (12), pp.e0209522. ⟨10.1371/journal.pone.0209522⟩. ⟨hal-02134577⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

25